Nadia Peragine
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Immunomodulatory effect of dasatinib plus blinatumomab versus ponatinib plus blinatumomab in newly diagnosed Ph+ acute lymphoblastic leukemia.
Journal: Leukemia
Published: August 26, 2025
NG2 Molecule Expression in Acute Lymphoblastic Leukemia B Cells: A Flow-Cytometric Marker for the Rapid Identification of KMT2A Gene Rearrangements.
Journal: Mediterranean journal of hematology and infectious diseases
Published: October 17, 2023
Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia.
Journal: Cancers
Published: February 08, 2023
Neoplastic bone marrow invasion:rapid exclusion of hematological disease by flow cytometric routine panels.
Journal: Blood cells, molecules & diseases
Published: October 02, 2022
Early CD49d downmodulation in chronic lymphocytic leukemia patients treated front-line with ibrutinib plus rituximab predicts long-term response.
Journal: Leukemia & lymphoma
Published: August 01, 2022
Utility of Flow Cytometry Ascitic Fluid Analysis for Rapid Diagnosis of B-Cell Peritoneal Lymphomatosis.
Journal: Mediterranean journal of hematology and infectious diseases
Published: June 07, 2022
Hairy cell leukaemia with low CD103 expression: A rare but important diagnostic pitfall.
Journal: British journal of haematology
Published: March 15, 2022
Repeated infusions of escalating doses of expanded and activated autologous natural killer cells in minimal residual disease-positive Ph+ acute lymphoblastic leukemia patients. A GIMEMA phase 1 trial.
Journal: American journal of hematology
Published: February 20, 2022
TH2/TH1 Shift Under Ibrutinib Treatment in Chronic Lymphocytic Leukemia.
Journal: Frontiers in oncology
Published: December 02, 2020
Last Updated: 09/26/2026